REG-Arix Bioscience PLC Holding(s) in Company

Arix BioscienceAnnouncement

24/01/2024 17:45

============

   Arix Bioscience PLC (ARIX)
   Holding(s) in Company

   24-Jan-2024 / 17:30 GMT/BST

   ══════════════════════════════════════════════════════════════════════════

   TR-1: Standard form for notification of major holdings

    

   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to
   the FCA in Microsoft Word format if possible) i
                                                                             
   1a. Identity of the issuer or the
   underlying issuer of existing shares to         Arix Bioscience Plc
   which voting rights are attached ii:
   1b. Please indicate if the issuer is a non-UK issuer (please mark with an
   “X” if appropriate)
   Non-UK issuer                                                          
   2. Reason for the notification (please mark the appropriate box or boxes
   with an “X”)
   An acquisition or disposal of voting rights                           X
   An acquisition or disposal of financial instruments                    
   An event changing the breakdown of voting rights                       
   Other (please specify) iii:                                            
   3. Details of person subject to the notification obligation iv
   Name                                     RTW Investments, LP
   City and country of registered office    New York, USA
   (if applicable)
   4. Full name of shareholder(s) (if different from 3.) v
   Name                                     RTW Biotech Opportunities
                                            Operating Ltd
   City and country of registered office    St Peter Port, Guernsey
   (if applicable)
   5. Date on which the threshold was       17/01/2024
   crossed or reached vi:
   6. Date on which issuer notified         22/01/2024
   (DD/MM/YYYY):
   7. Total positions of person(s) subject to the notification obligation
                       % of voting    % of voting
                         rights     rights through  Total of  Total number of
                       attached to     financial    both in % voting rights
                      shares (total   instruments    (8.A +   held in issuer
                        of 8. A)    (total of 8.B 1   8.B)    (8.A + 8.B) vii
                                       + 8.B 2)
   Resulting
   situation on the
   date on which      25.52         0.00%           25.52%    33,023,210
   threshold was
   crossed or reached
   Position of
   previous
   notification (if   n/a           n/a             n/a        

   applicable)
                                                                       

    

   8. Notified details of the resulting situation on the date on which the
   threshold was crossed or reached viii
   A: Voting rights attached to shares
   Class/type of Number of voting rights ix         % of voting rights
   shares
                      Direct          Indirect          Direct      Indirect
   ISIN code (if
   possible)         (DTR5.1)         (DTR5.2.1)       (DTR5.1)    (DTR5.2.1)
   GB00BD045071  0                33,023,210        0.00%          25.52%
                                                                    
                                                                    
   SUBTOTAL 8. A             33,023,210                      25.52%
    

    
   B 1: Financial Instruments according to DTR5.3.1R (1) (a)
                                              Number of voting
   Type of                  Exercise/         rights that may be   % of
   financial     Expiration Conversion Period acquired if the      voting
   instrument    date x     xi                instrument is        rights

                                              exercised/converted.
                                                                    
                                                                    
                                                                    
                            SUBTOTAL 8. B 1                         
    

    
   B 2: Financial Instruments with similar economic effect according to
   DTR5.3.1R (1) (b)
   Type of                  Exercise/    Physical or cash Number   % of
   financial   Expiration   Conversion                    of       voting
   instrument  date x       Period xi    Settlement xii   voting   rights
                                                          rights
                                                                    
                                                                    
                                                                    
                                         SUBTOTAL 8.B.2             
    

    
                                                                    

    

   9. Information in relation to the person subject to the notification
   obligation (please mark the

   applicable box with an “X”)
   Person subject to the notification obligation is not controlled by
   any natural person or legal entity and does not control any other      
   undertaking(s) holding directly or indirectly an interest in the
   (underlying) issuer xiii
   Full chain of controlled undertakings through which the voting
   rights and/or the
   financial instruments are effectively held starting with the           
   ultimate controlling natural person or legal entity (please add
   additional rows as necessary) xiv
                         % of voting    % of voting rights   Total of both if
                        rights if it     through financial   it equals or is
         Name xv        equals or is     instruments if it   higher than the
                       higher than the  equals or is higher     notifiable
                         notifiable     than the notifiable     threshold
                          threshold          threshold
   Roderick Wong                                              
   RTW Investments GP                                         
   LLC
   RTW Investments, LP                                        
   RTW Biotech                                                
   Opportunities Ltd
   RTW Biotech
   Opportunities       25.52%          0.00%                 25.52%
   Operating Ltd
                                                              
    
   10. In case of proxy voting, please identify:
   Name of the proxy holder             
   The number and % of voting rights    
   held
   The date until which the voting      
   rights will be held
    
   11. Additional information xvi
    
                                                                       

    

   Place of completion London, UK
   Date of completion  19/01/2024

    

    

    

    

    

    

   ══════════════════════════════════════════════════════════════════════════

   Dissemination of a Regulatory Announcement, transmitted by EQS Group.
   The issuer is solely responsible for the content of this announcement.

   ══════════════════════════════════════════════════════════════════════════

   ISIN:           GB00BD045071
   Category Code:  HOL
   TIDM:           ARIX
   LEI Code:       213800OVT3AHQCXNIX43
   OAM Categories: 2.3. Major shareholding notifications
   Sequence No.:   299502
   EQS News ID:    1822379


    
   End of Announcement EQS News Service

   ══════════════════════════════════════════════════════════════════════════

    1 fncls.ssp?fn=show_t_gif&application_id=1822379&application_name=news&site_id=reuters8

References

   Visible links


============